Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a study of HMB plus amino acids in older men with prostate cancer starting androgen deprivation therapy (ADT). The investigators hypothesize that the use of this nutritional supplementation will decrease the loss of muscle mass and strength that occurs when men start ADT.
Epistemonikos ID: e424da89f9790cf64e381681470dab1ffb3149e2
First added on: May 11, 2024